Seeking Alpha

Despite an earlier downgrade to Market Perform by RBC this morning, Wells Fargo says Celgene...

Despite an earlier downgrade to Market Perform by RBC this morning, Wells Fargo says Celgene (CELG -0.6%) looks attractive at current levels. After meeting with management, Wells says it's pleased with the way Q2 is going and thinks the stock could rally on the back of the E.U.'s label decision on Revlimid, and that the drug is positioned for solid growth.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|